Literature DB >> 19488907

Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma.

Yazhou Cui1, Denglu Zhang, Qing Jia, Tianliang Li, Weidong Zhang, Jinxiang Han.   

Abstract

We identified a group of hypoxia-regulated proteins upregulated in microdissected pancreatic cancer nests compared with normal pancreatic ducts. Immunohistochemical study further validated that pancreatic cancers had significantly higher expression levels of glucose-regulated protein 78, macrophage migration inhibitory factor and annexin A5 than normal pancreas tissues, these protein biomarkers also demonstrated high receiver operating characteristic curves in discriminating pancreatic cancers from normal pancreas. In conclusion, our study indicated a link between pancreatic cancer and hypoxia-regulated proteins. Glucose-regulated protein 78, macrophage migration inhibitory factor and annexin A5 might be promising targets for pancreatic cancer diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19488907     DOI: 10.1080/07357900802672746

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  9 in total

1.  Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry.

Authors:  Joao A Paulo; Linda S Lee; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Pancreas       Date:  2012-03       Impact factor: 3.327

2.  MALDI-Mass Spectrometric Imaging Revealing Hypoxia-Driven Lipids and Proteins in a Breast Tumor Model.

Authors:  Lu Jiang; Kamila Chughtai; Samuel O Purvine; Zaver M Bhujwalla; Venu Raman; Ljiljana Paša-Tolić; Ron M A Heeren; Kristine Glunde
Journal:  Anal Chem       Date:  2015-06-04       Impact factor: 6.986

3.  Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma.

Authors:  Shaiju K Vareed; Vadiraja B Bhat; Christopher Thompson; Vihas T Vasu; Damian Fermin; Hyungwon Choi; Chad J Creighton; Sitaram Gayatri; Ling Lan; Nagireddy Putluri; Gagan Singh Thangjam; Punit Kaur; Mohsen Shabahang; Judith G Giri; Alexey I Nesvizhskii; Alexander A A Asea; Anil G Cashikar; Arundhati Rao; James McLoughlin; Arun Sreekumar
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

Review 4.  Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.

Authors:  Yantian Fang; Qizhi Yao; Zongyou Chen; Jianbin Xiang; Fisher E William; Richard A Gibbs; Changyi Chen
Journal:  Med Sci Monit       Date:  2013-10-31

5.  Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.

Authors:  Laetitia Ligat; Nathalie Saint-Laurent; Aïcha El-Mrani; Véronique Gigoux; Talal Al Saati; Richard Tomasini; Jérémy Nigri; Sébastien Dejean; Frédéric Pont; Romain Baer; Julie Guillermet-Guibert; Pierre Cordelier; Frédéric Lopez; Marlène Dufresne
Journal:  Br J Cancer       Date:  2015-10-29       Impact factor: 7.640

6.  "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.

Authors:  Gary A Clawson; Gail L Matters; Ping Xin; Christopher McGovern; Eric Wafula; Claude dePamphilis; Morgan Meckley; Joyce Wong; Luke Stewart; Christopher D'Jamoos; Naomi Altman; Yuka Imamura Kawasawa; Zhen Du; Loren Honaas; Thomas Abraham
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

7.  The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.

Authors:  Tongde Du; Hongchang Li; Yongsheng Fan; Lin Yuan; Xiaodan Guo; Qiong Zhu; Yuying Yao; Xin Li; Chunlei Liu; Xinhe Yu; Zhaofei Liu; Chun-Ping Cui; Chuanchun Han; Lingqiang Zhang
Journal:  Nat Commun       Date:  2019-07-02       Impact factor: 14.919

8.  Possible proteomic biomarkers for the detection of pancreatic cancer in oral fluids.

Authors:  O Deutsch; Y Haviv; G Krief; N Keshet; R Westreich; S M Stemmer; B Zaks; S P Navat; R Yanko; O Lahav; D J Aframian; A Palmon
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

9.  Macrophage-tumor cell fusions from peripheral blood of melanoma patients.

Authors:  Gary A Clawson; Gail L Matters; Ping Xin; Yuka Imamura-Kawasawa; Zhen Du; Diane M Thiboutot; Klaus F Helm; Rogerio I Neves; Thomas Abraham
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.